- Guidelines of Czech Association for Thrombosis and Haemostasis of the Czech Medical Association of J. E. Purkyně for safety treatment with new oral anticoagulants (NOAC) - dabigatran etexilate, apixaban and rivaroxaban2015 | First Faculty of Medicine
- Dabigatran etexilate - a new promising antithrombotic agent2010 | First Faculty of Medicine, Third Faculty of Medicine
- Dabigatran-etexilate (Pradaxa®) in prevention of strokes in patients with atrial fibrillation2012 | Publication without faculty affiliation
- Dabigatran etexilate - a breakthrough in antithrombotic therapy in cardiology?2011 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 1160.113Publication without faculty affiliation
- Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation2013 | Third Faculty of Medicine
- The first experience with dabigatran antidote in the University Hospital Pilsen2016 | Faculty of Medicine in Pilsen
- Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children2020 | Second Faculty of Medicine
- Dabigatran in the treatment of recurrent deep vein thrombosis and pulmonary embolism2015 | Faculty of Medicine in Hradec Králové
- Dabigatran - clinical evidence for treatment in patients with thromboembolism2016 | First Faculty of Medicine
- Dabigatran in the prevention of stroke in patients with atrial fibrilation2011 | First Faculty of Medicine, Third Faculty of Medicine
- Oral antithrombotic treatment in 2013 - review of drugs, indications and complications management2013 | First Faculty of Medicine, Third Faculty of Medicine
- Anticoagulants in the treatment of deep vein thrombosis2013 | First Faculty of Medicine, Third Faculty of Medicine
- Prevention of cardioembolic stroke2012 | First Faculty of Medicine
- RE-DUAL PCI trial - percutaneous coronary intervention in patient with atrial fibrillation treated with dabigatran2018 | Publication without faculty affiliation
- New anticoagulants - When is it possible to replace warfarin nowadays?2012 | First Faculty of Medicine
- Comparison of new oral anticoagulants from the perspective of pharmacological features and clinical trials2013 | First Faculty of Medicine, Third Faculty of Medicine
- Anticoagulant Therapy in the Prevention and Treatment of Ischemic Stroke2010 | First Faculty of Medicine
- The role of pharmacogenetics and drug interactions in the treatment with direct oral anticoagulants2019 | Third Faculty of Medicine
- Application of spectroscopic imaging for characterizing API: polymer systems as a screening tool for the development of potential amorphous solid dispersions2017 | Faculty of Pharmacy in Hradec Králové
- Clinical use of the new antithrombotics2010 | Faculty of Medicine in Hradec Králové
- Coagulation monitoring and management of bleeding complications in treatment using new peroral anticoagulants from a haematologist perspective2013 | Publication without faculty affiliation
- Anticoagulation therapy2023 | Publication without faculty affiliation
- Účinnost a bezpečnost dabigatranu při podávání dle SPC a evropských doporučení. Komentář k článku Patient outcomes using the European label for dabigatran2017 | Publication without faculty affiliation
- The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study2013 | Publication without faculty affiliation